Ameritas Advisory Services’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $609K | Buy |
5,492
+616
| +13% | +$68.3K | 0.03% | 457 |
|
|
2025
Q1 | $511K | Buy |
4,876
+96
| +2% | +$10.1K | 0.02% | 563 |
|
|
2024
Q4 | $442K | Sell |
4,780
-760
| -14% | -$70.2K | 0.02% | 622 |
|
|
2024
Q3 | $464K | Buy |
5,540
+348
| +7% | +$29.2K | 0.02% | 560 |
|
|
2024
Q2 | $356K | Sell |
5,192
-2,167
| -29% | -$149K | 0.01% | 683 |
|
|
2024
Q1 | $518K | Buy |
7,359
+1,474
| +25% | +$104K | 0.02% | 545 |
|
|
2023
Q4 | $461K | Buy |
5,885
+177
| +3% | +$13.9K | 0.03% | 445 |
|
|
2023
Q3 | $428K | Buy |
+5,708
| New | +$428K | 0.02% | 539 |
|
|
2023
Q2 | – | Sell |
-7,564
| Closed | -$647K | – | 1337 |
|
|
2023
Q1 | $647K | Sell |
7,564
-3,369
| -31% | -$288K | 0.03% | 421 |
|
|
2022
Q4 | $939K | Buy |
10,933
+2,052
| +23% | +$176K | 0.04% | 367 |
|
|
2022
Q3 | $548K | Buy |
8,881
+585
| +7% | +$36.1K | 0.03% | 410 |
|
|
2022
Q2 | $513K | Buy |
8,296
+46
| +0.6% | +$2.85K | 0.03% | 445 |
|
|
2022
Q1 | $490K | Buy |
8,250
+1,044
| +14% | +$62K | 0.02% | 506 |
|
|
2021
Q4 | $523K | Buy |
+7,206
| New | +$523K | 0.02% | 493 |
|